This study shows that 4HC exerts potent cytotoxic effects on MYCN-amplified NB cells and that it can be combined with clinically approved anticancer drugs, doxorubicin or cisplatin, to potentiate NB cell death. Here, MYCN is linked to neuroblastoma.